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Summary As part of the Department of Health's National Breast Screening Trial a seven year study is in
progress in Huddersfield to assess the effect of an educational programme in Breast Self Examination (BSE)
on the mortality due to breast cancer among women aged 45-64. The initial cohort of 22,484 women have
completed 3 years in the study and show a higher than expected annual incidence rate of breast cancer. There
is no significant difference in the incidence rates between those who attended meetings for BSE instruction
and those who did not. Similarly there is no difference in stages of presentation of cancers between attenders
and non-attenders at these meetings and also between cancers detected in the first, second and third years.
Those who discovered abnormalities during self sexamination, however, presented with smaller lumps
compared to other women. Assessment of prognostic factors do not at this time provide sufficient evidence to
show that a community-based BSE campaign will result in a significant improvement in the stage of breast
cancer presentation.
The growing awareness that mortality from breast
cancer can be reduced by early diagnosis and
treatment, and that many early cancers can be
detected by a combination of clinical examination
and breast radiography has aroused wide-spread
interest in breast screening (Shapiro, 1977;
Lundgren & Jakobsson, 1979). However, to
introduce such a universal screening programme
would be difficult and costly. Search therefore
continues for an effective method of screening which
is acceptable to women, practical and cost effective.
One possible method of providing early detection at
a reduced cost is to encourage women to examine
their own breasts regularly. Reports have shown
that breast self-examination (BSE) can be done
effectively and that when cancer is detected by self-
examination it is often at an early and favourable
stage (Huguley & Brown, 1981). Studies of BSE are
currently underway in Nottingham and
Huddersfield as part of a National Breast Screening
Trial (Dept. of Health & Social Security Working
Group, 1982). Women between 45 and 64 years of
age are being invited to receive instruction in BSE.
The response is being assessed and the stage of
presentation and mortality rate of breast cancer in
these women is being monitored. In addition, open
access clinics have been set up to enable women in
the study population to obtain prompt advice.
In Huddersfield the first round of invitations was
completed within 15 months of starting. The initial
cohort of women has now been followed up for
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three full years. In addition to the main
investigation a number of parallel studies are also
being undertaken to evaluate the psychological
effects of the programme.
Subjects and method
All women aged between 45 and 64 years, living in
the Huddersfield Health District, have been invited
at least once to attend a meeting where instruction
in BSE is given. The women are invited, in small
groups, by a personal letter to meetings held in
various parts of the district and every woman has a
choice of venue and time. At these meetings the
importance of early diagnosis of breast cancer is
emphasised and the technique of BSE demonstrated
by means of a film ("Your Life in Your Hands" -
WNCCC). The attenders at the meetings are given
a specially designed calendar card on which to
record the details of their subsequent BSE practice.
Postal contact is maintained with all women in the
study, by recalling and replacing the calendar cards
annually and by other means such as annual
newsletters and BSE leaflets. Wide publicity is also
given to the study through newspaper articles and
advertisements.
The education meetings are complemented by six
open access clinics in different parts of the district.
A woman in the study age group, with an abnormal
breast sign or symptom, whether she accepted an
invitation to an education meeting or not, may
attend, without an appointment, any one of these
clinics. If necessary, she is then referred directly to
the hospital breast clinic for treatment. Some
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patients, however, prefer to seek advice from their
own family doctors and if then referred to hospital
are included as a separate sub-group.
Data regarding patient delay, presenting
symptom(s), mode of discovery of abnormality,
clinical staging and pathological axillary nodal
status of all new cancers have been analysed.
Results
Of the initial cohort of 22,484 women 6,724 (30%)
responded to the first invitation and attended an
educational meeting. Response from younger
women (32% from those between 45-49 as well as
50-54) was significantly higher than that from older
women (10% from those between 55-59 and 25%
from those between 55-59). X2 =99.67, df=3,
P<0.001.
Number of cancers detected
During the first 3 years of the study a total of 148
women were diagnosed as having breast cancer, 5
having bilateral lesions. Forty-six including 3
bilateral cancers occurred in the first year, 57
(2 bilateral) in the second year, and 45 (no bilateral)
in the third year. Table I shows the incidence rates
and numbers presenting in each of the three years
for those women who attended the educational
meeting and for those who were within the same
age group, but who did not attend. The average
incidence rate of 2.27 per thousand women was
higher than the expected rate of 1.5 per thousand.
Presenting symptoms
One hundred and ten women presented with a
lump in the breast and this was the commonest
symptom. Fifteen women complained of a breast
deformity or inversion of the nipple. For 10 the
only presenting symptom was breast pain. Two
women noticed a discharge from the nipple, and 13
had symptoms due to advanced disease. Three
women attended the clinic with no symptoms.
Mode ofdiscovery ofpresenting symptoms
The mode of discovery was classified as either BSE
or chance-finding, and only considered relevant if
the presenting symptom was either a lump or
deformity. As the study progressed it became
apparent that a number of women regularly
examine themselves, yet still discover abnormal
signs in between such regular examinations. These
were considered as having discovered their lesions
by chance and included in the chance finding group.
Table II gives the results for the different
methods of detection. Seventy-three cancers were
detected by chance and 40 on the occasions of
regular examinations. In 36 women the lesions were
detected either by a doctor, or the symptoms were
such that they could not be included in the BSE or
"chance" group. These included women who
presented with pain, fungating lesions, symptoms
due to metastatic disease, etc. (and were recorded as
"other"). In four cases the method of detection was
not recorded.
Table II Method of discovery of presenting symptoms
(Percentages in parentheses)
Attenders Non-attenders Total
Chance 13(20) 60(55) 73(48)
BSE 23(52) 17(16) 40(26)
Other 7(16) 29(27) 36(23)
Unknown 1 (2) 3 (5) 4 (3)
Totals 44 109 153
Table 1 Incidence of breast cancer
Year I Year 2 Year 3
No. of Rate per No. of Rate per No. of Rate per
cancers thousand cancers thousand cancers thousand
Attenders
n=6,724 12 1.78 17 2.53 15 2.23
Non-attenders
n= 15,760 37 2.34 42 2.66 30 1.90
Total
n = 22,484 49 2.18 59 2.62 45 2.00
Average annual incidence rate 2.27 per thousand.
Expected rate 1.5 per thousand (X2 =7.02 P<0.01).
N.B. The study population is in the 45-64 age group.BREAST SELF-EXAMINATION: CLINICAL RESULTS 9
Patient delay
Patient delay is defined as the interval between the
onset of symptom(s) and attendance at a clinic. One
hundred and fifty-three cancers were diagnosed in
148 women. Seventy-two of the cancers were
diagnosed within one month of the patient noticing
an abnormality, 34 between one and three months,
22 between three and twelve months. For eight
patients there was no information available.
Of the 44 women who attended an educational
meeting 18 (44%) visited a clinic within a month,
compared with 54 (53%) of the 101 who had not
attended a meeting. Of the 40 women who detected
an abnormality by BSE, 19 (48%) sought advice
within a month, compared with 53 (50%) of 105
women who presented within a month but did not
practise BSE. For those women who detected their
cancers by BSE (40) it appears that more women
who attended an educational meeting delayed
seeking advice for over one month (17/23) than in
the non-attenders (4/17).
Clinical staging
Table III gives the clinical staging (TNM) of the
invasive cancers for the attenders and non-attenders
at educational meetings.
The mean size of all tumours was 3.4cm (range
0-12 cm), and for the non-attenders the mean size
was 3.5cm (range 0.5-8cm). However, 45% of the
attenders presented with lesions 2.0 cm in size,
compared with 31% of the non-attenders. This
trend was reversed for lesions >5 cm, being 11% for
the attenders, and 27% for the non-attenders.
Pathological node status
Of the 153 cancers, 14 were non-invasive, 2 from
attenders and 12 from non-attenders at meetings.
Eighteen women had no surgery and 19 had
limited surgery to the primary lesion without
removal of axillary nodes. Of the remaining 102
invasive cancers where the pathological status of
the axillary nodes were known 32 were from
attenders and 70 from non-attenders. Seventeen of
the former (53%) and 38 (54%) of the latter were
node negative.
Of the 40 lesions discovered by BSE, 5 were non-
invasive cancers. Table IV compares the clinical
stages of the BSE detected invasive cancers (35)
with those detected by other means (109 invasive
and 4 non-invasive). The results indicate that the
BSE detected cancers tend to be smaller than those
discovered by other means.
This tendency is also evident when the
pathological status of the axillary nodes of the two
groups of cancers is compared. Of the 102 invasive
cancers where the axillary nodal status is known 27
were detected by BSE and 75 by other means.
Sixteen of the former (59%) and 39 (52%) of the
latter were node negative.
Discussion
The reported rates of breast cancer detection vary
widely for different screening programmes. For
example the rate in New York was 2.7 per
thousand women screened (Shapiro et al., 1973) and
in the UK rates of 7.8 per thousand (Wright &
Table III Clinical stages of invasive cancers (n= 134). Comparison between the cancers detected from attenders and
those from non-attenders
Clinically node Clinically node
negative (No) positive (N1 and N2) Total
2cm or less Attenders 8l35 1 13 19(45% of attenders with cancer)
(To and T1) Non-attenders 27J 2J 29(31% of non-attenders with cancer)
>2- cm Attenders 12l41 5l14 17(40% of attenders with cancer)
(T2) Non-attenders 29J 93 38(41% of non-attenders with cancer)
>5cm and
advanced tumours Attenders 5 16 1 15 6(15% of attenders with cancer)
(T3T4 and M1) Non-attenders llJ 14J 25(27% of non-attenders with cancer)
Totals Attenders with
cancer 25(60%) 17(40%) 42
Non-attenders
with cancer 67(73%) 25(27%) 92
aIn all, there are 139 invasive cancers, but 5 could not be staged as the relevant information was not available.10 J. PHILIP et al.
Table IV Clinical stages of invasive cancers (n= 134'). Comparison between the cancers detected by BSE and those
detected by other means.
Clinically node Clinically node
negative (No) positive (N1 and N2) Total
2cm or less BSE 12 2 14(40% BSE detected cancer)
(To and T1) Non-BSE 31 3 34(31% cancer discovered by other means)
>2- cm BSE 13 2 15(43% BSE detected cancer)
(T2) Non-BSE 30 10 40(37% cancer discovered by other means)
>5cm and
advanced tumours BSE 4 2 6(17% BSE detected cancer)
(T3T4 and M1) Non-BSE 11 14 25(23% cancer discovered by other means)
Totals BSE detected
cancer 29(83%) 6(17%) 35
Cancer
discovered
by other
means 72(66%) 37(34%) 109
aIn all there are 139 invasive cancers but 5 could not be staged as the relevant information was not available.
Davey, 1975), 11.3 per thousand (Thomas, 1975),
and 12 per thousand (Chamberlain, 1975) have been
reported. These differences are believed to be due to
different methods of screening, varying age groups
of women screened and different procedures
regarding inclusion or exclusion of symptomatic
women. These figures are therefore not directly
comparable with the results presented here which
show an annual overall incidence of 2.27 per
thousand as against an expected incidence for
women of this age of 1.5 per thousand (P<0.01)
(Office of Population Census and Surveys - Cancer
Statistics, 1976). Fifty-four of the 153 new cancers
were in women who attended an educational
meeting and the rest in those who did not. This
gives an annual incidence for attenders and non-
attenders at meetings of 2.18 and 2.3 respectively. It
has been shown that women who respond to breast
screening services can be self-selective in some way,
and have a higher cancer incidence than expected
(Chamberlain, 1978), but the comparable incidence
rates in this study of women who attended BSE
educational meetings and those who did not suggest
no process of self-selection in attending the
meetings. The higher than expected overall
incidence rate, however, suggests that the campaign
has in.a small way influenced the behavior of all the
women in the study.
When the three year study period is divided into
three monthly intervals, the average number of
cancers detected from the study population, in each
of the three monthly intervals, is found to be fairly
constant. However, the number detected from the
attenders at educational meetings in the first three
months of each year is higher than the average for
the rest of the period. One possible cause for this is
that past attenders at meetings are contacted by
post each year with a newsletter and replacement
calendar.
At the teaching sessions the importance of
prompt consultation for any suspected change in
the breasts is emphasised in order to encourage
those with symptoms to seek early advice. In order
to help the study population obtain prompt help we
opened the six free access clinics in various parts of
the district. As a result it might be expected that in
the early stages of the campaign more cancers than
estimated would be detected with some being at a
relatively advanced stage. This increase in the
diagnosis rate is often clearly seen in direct
screening of asymptomatic women. However this
study has shown that it is much less obvious in a
BSE campaign where the emphasis is on education
and no clinical or radiological examination is
undertaken until the woman herself detects and
reports an abnormality. Also, it is difficult to
predict how soon it will be before any significant
difference in stage presentation might become
apparent. So far in this study those cancers detected
in the first year show no features significantly
different from those detected in subsequent years
(Table V).
The clinical features of the cancers detected from
attenders and non-attenders at educational meetings
appear very similar. This similarity may be due
partly to the facility of self-referral clinics provided
for all women in the study, and the constant
reminder in the press of the value of early detection.BREAST SELF-EXAMINATION: CLINICAL RESULTS 11
Table V Comparison of cancers detected in the first, second and third years
Year 1 Year 2 Year 3 Total
Number of cancers
Attenders at educational
meetings 12 17 15 44
Non-attenders 37 42 30 109
Total 49 59 45 153
BSE detected cancers
Attenders at educational
meetings 6 12 5 23
Non-attenders 5 9 3 17
Total 11 21 8 40
Non-invasive cancers
Attenders at educational
meetings 0 0 2 2
Non-attenders 4 5 3 12
Total 4 5 5 14
Clinically early cancers
(ToTjT2NO)
Attenders at educational
meetings 7 12 11 30
Non-attenders 19 21 16 56
Total 26 33 27 86
Pathologically node
negative cancers
Attenders at educational
meetings 5 6 6 17
Non-attenders 14 13 11 38
Total 19 19 17 55
We have made a distinction between cancers
detected by BSE and cancers detected between such
examinations which are classified as chance
detected, and explains the low number of BSE
detected cancers in this series. However, it is
important to note that just over half of the cancers
from those who attended a teaching session were
detected by BSE as against only 16% from non-
attenders.
Whereas it has been shown that cancer at an
early stage can be detected by women who examine
themselves regularly no information exists regarding
the time needed for a community-based BSE
campaign to produce an overall improvement in the
stage of cancer presentation. This seven year study
is now in its fourth year, and until further results
are available, we feel that community-based BSE
campaigns should be regarded as of unproven value
in the early detection of breast cancer.
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